Viral entry and NS1 as potential antiviral drug targets

Aravinda M. de Silva; Félix A. Rey; Paul R. Young; Rolf Hilgenfeld; Subhash G. Vasudevan

doi:10.1007/978-981-10-8727-1_8

Viral entry and NS1 as potential antiviral drug targets

Aravinda M. de Silva, Félix A. Rey, Paul R. Young, Rolf Hilgenfeld^*, Subhash G. Vasudevan

^*Corresponding author for this work

Institute of Biochemistry

Abstract

A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

Original language	English
Title of host publication	Advances in Experimental Medicine and Biology
Number of pages	7
Volume	1062
Place of Publication	Singapore
Publisher	Springer Singapore
Publication date	01.01.2018
Pages	107-113
ISBN (Print)	978-981-10-8726-4
ISBN (Electronic)	978-981-10-8727-1
DOIs	https://doi.org/10.1007/978-981-10-8727-1_8
Publication status	Published - 01.01.2018

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-981-10-8727-1_8

Cite this

@inbook{110f67a0b8464e70a66e4f41c2fd928b,

title = "Viral entry and NS1 as potential antiviral drug targets",

abstract = "A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.",

author = "{de Silva}, {Aravinda M.} and Rey, {F{\'e}lix A.} and Young, {Paul R.} and Rolf Hilgenfeld and Vasudevan, {Subhash G.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/978-981-10-8727-1_8",

language = "English",

isbn = "978-981-10-8726-4",

volume = "1062",

series = "Advances in Experimental Medicine and Biology",

publisher = "Springer Singapore",

pages = "107--113",

booktitle = "Advances in Experimental Medicine and Biology",

}

Viral entry and NS1 as potential antiviral drug targets. / de Silva, Aravinda M.; Rey, Félix A.; Young, Paul R. et al.
Advances in Experimental Medicine and Biology. Vol. 1062 Singapore: Springer Singapore, 2018. p. 107-113 (Advances in Experimental Medicine and Biology; Vol. 1062).

Research output: Chapters in Books/Reports/Conference Proceedings › Chapter › peer-review

TY - CHAP

T1 - Viral entry and NS1 as potential antiviral drug targets

AU - de Silva, Aravinda M.

AU - Rey, Félix A.

AU - Young, Paul R.

AU - Hilgenfeld, Rolf

AU - Vasudevan, Subhash G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

AB - A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

UR - http://www.scopus.com/inward/record.url?scp=85048015735&partnerID=8YFLogxK

U2 - 10.1007/978-981-10-8727-1_8

DO - 10.1007/978-981-10-8727-1_8

M3 - Chapter

AN - SCOPUS:85048015735

SN - 978-981-10-8726-4

VL - 1062

T3 - Advances in Experimental Medicine and Biology

SP - 107

EP - 113

BT - Advances in Experimental Medicine and Biology

PB - Springer Singapore

CY - Singapore

ER -

Viral entry and NS1 as potential antiviral drug targets

Abstract

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this